ClinChoice · 7 hours ago
Pharmacovigilance (PV) Literature Monitoring Consultant
Maximize your interview chances
Insider Connection @ClinChoice
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Performs screening, abstracting, indexing, and editing functions
Monitors the quality, accuracy, and timeliness of biomedical literature screening, adverse event reporting, abstracting, and indexing
Assists with the acquisition and, where applicable, translation of published biomedical literature, including conference abstracts
Develops, with input from internal stakeholders and knowledge of current regulatory requirements, article selection, adverse event reporting, editorial, and indexing policies and procedures
Ensures comprehensive creation, maintenance, and communication of all standard operating procedures (SOPs), guidelines, and job aids related to these functions
Assists with the training of screeners/abstractors/indexers, and internal team members
Assists with end-user training and request fulfillment
Participates in the management of published literature and conference abstract acquisition and translation
Liaises with regulatory groups to ensure search request results meet current regulatory requirements
Collaborates with pharmacovigilance teams to meet current literature-related adverse event monitoring requirements, including collaboration with ex-US PV groups to develop of journal lists for adverse event screening
Assists in the evaluation of proposals and developments sponsored by intra-company information or systems units for applicability to the specific information needs of Clinical Literature Information Center (CLIC) end-users
Collaborates with internal and external organizations in the development and integration of literature-related systems and information
Maintains personal awareness of developments in the fields of medical information, regulatory policy, adverse event reporting, information storage and retrieval, and information services
Participates in the collaboration with our Company's IT to maintain the Company Product Literature Database to ensure the maximum performance, reliability, data integrity, security, copyright compliance, and precision and recall of the database. Leads end-user and system application development
Participates in data processing, harmonization, deduplication, and standardization activities
Participates in the development, maintenance, and control activities of CLIC terminology to ensure optimal precision and recall of CLIC data
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Degree in life sciences, information science, pharmacy, or related scientific discipline plus literature-related regulatory reporting
Bachelor’s and 5+ years
3+ years of work with biomedical literature and pharmacovigilance activities
Basic working knowledge of biomedical literature and information storage and retrieval systems
An understanding of US and ex-US pharmaceutical regulations
Good writing skills
Attention to detail
Good time management skills
Foreign language proficiency is desirable
Working knowledge of information storage and retrieval systems
Preferred
Experience with audits and inspections
Knowledge of biomedical literature sources, content, and indexing
Knowledge of commercial biomedical database structure, content, and content search/retrieval
Familiarity with copyright compliance
Familiarity with the application of semantic technologies, Natural Language Processing (NLP), Machine Learning (ML) or Artificial Intelligence (AI)
Experience with the SDLC (system development lifecycle)
Company
ClinChoice
ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide.
Funding
Current Stage
Late StageTotal Funding
$212MKey Investors
Legend CapitalGoldman Sachs
2022-07-04Series E· $150M
2019-10-25Series D· $62M
2019-05-01Series C· undefined
Recent News
2023-07-18
Bloomberg.com
2023-07-07
2023-03-02
Company data provided by crunchbase